King Faisal Specialist Hospital and Research Centre Seeks to Achieve Self-Sufficiency in Radiopharmaceuticals within the Kingdom_01
King Faisal Specialist Hospital and Research Centre Seeks to Achieve Self-Sufficiency in Radiopharmaceuticals within the Kingdom_02
RIYADH, Saudi Arabia, Oct. 30, 2023 (GLOBE NEWSWIRE) — For the previous 4 a long time, the Cyclotron and Radiopharmaceuticals Department at King Faisal Specialist Hospital and Research Centre (KFSH&RC) has been addressing the wants of native and regional medical facilities for radiopharmaceuticals utilized in diagnosing and treating numerous specialised ailments.
Since its institution, the division has produced over 25 kinds of radiopharmaceuticals with a manufacturing capability exceeding 600,000 radiopharmaceutical preparations. The division continues to supply its merchandise to over 50 specialised Saudi medical facilities, aiming to attain self-sufficiency within the subject of radiopharmaceuticals within the Kingdom of Saudi Arabia.
During the Global Health Exhibition that commenced yesterday within the capital metropolis of Riyadh, the place KFSH&RC participates as a strategic well being companion, the hospital highlights the division’s pioneering function in nuclear drugs. This contains enhancing the capabilities of healthcare suppliers in each analysis and training, in addition to guaranteeing the standard within the manufacturing and distribution of radiopharmaceuticals to hospitals throughout the Kingdom and past.
The Cyclotron and Radiopharmaceuticals Department aspires to change into a diagnostic and molecular imaging heart and the primary facility for Technetium-99m (Tc-99m) mills within the Kingdom. It conducts analysis to develop high-quality radiopharmaceuticals for KFSH&RC and different hospitals all through the Kingdom to fulfill all healthcare wants of sufferers. The division adheres to high-quality requirements for automated high quality management and assurance whereas striving to advance cyclotron expertise, exact radiopharmaceutical manufacturing, and the event of radiopharmaceuticals utilized in positron emission tomography/computed tomography (PET/CT).
The division considerably emphasizes high quality, with an built-in product high quality management and administration unit, manufacturing supplies following Good Manufacturing Practices (GMP), the Saudi Food and Drug Authority (SFDA) requirements, and ISO 9001 worldwide high quality administration system requirements. All operational processes are subjected to rigorous monitoring for the periodic analysis of supplies, guaranteeing their steady suitability. This strategy has led to a exceptional buyer satisfaction charge exceeding 95%.
KFSH&RC is globally acknowledged for offering specialised healthcare and is a pacesetter in innovation, superior medical analysis, and medical training. The establishment actively seeks to develop medical applied sciences and improve the usual of healthcare worldwide, partnering with main native, regional, and worldwide organizations to ship world-class providers in scientific, analysis, and academic domains.
Contact info:
[email protected]
Photos accompanying this announcement are available at
https://www.globenewswire.com/NewsRoom/AttachmentNg/ad78d2ea-0d15-45ae-a3bd-cd25f7bf7ab9
https://www.globenewswire.com/NewsRoom/AttachmentNg/1d1f90e9-3a44-43cf-8812-af6760e2d0b2
